BCN-PEG4-HyNic
Code | Size | Price |
---|
TAR-T38997-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T38997-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
BCN-PEG4-HyNic is a cleavable four-unit PEG linker utilized in ADC synthesis for coupling drugs to antibodies, creating antibody-drug conjugates (ADCs).
CAS:
1507370-54-8
Molecular Weight:
499.612
Purity:
0.98
SMILES:
[H][C@@]12[#6]-[#6]C#C[#6]-[#6][C@]1([H])[#6@H]2-[#6]-[#8]-[#6](=O)-[#7]-[#6]-[#6]-[#8]-[#6]-[#6]-[#8]-[#6]-[#6]-[#7]-[#6](=O)-c1ccc(-[#7]\[#7]=[#6](\[#6])-[#6])nc1
References
Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.